Prostaglandin E2 Stimulates the Expansion of Regulatory Hematopoietic Stem and Progenitor Cells in Type 1 Diabetes

Hematopoietic stem and progenitor cells (HSPCs) are multipotent stem cells that have been harnessed as a curative therapy for patients with hematological malignancies. Notably, the discovery that HSPCs are endowed with immunoregulatory properties suggests that HSPC-based therapeutic approaches may b...

Descripción completa

Detalles Bibliográficos
Autores principales: Ben Nasr, Moufida, D’Addio, Francesca, Malvandi, Amir Mohammad, Faravelli, Silvia, Castillo-Leon, Eduardo, Usuelli, Vera, Rocchio, Francesca, Letizia, Teresa, El Essawy, Abdel Basset, Assi, Emma, Mameli, Chiara, Giani, Elisa, Macedoni, Maddalena, Maestroni, Anna, Dassano, Alice, Loretelli, Cristian, Paroni, Moira, Cannalire, Giuseppe, Biasucci, Giacomo, Sala, Marco, Biffi, Alessandra, Zuccotti, Gian Vincenzo, Fiorina, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018202/
https://www.ncbi.nlm.nih.gov/pubmed/29971065
http://dx.doi.org/10.3389/fimmu.2018.01387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018202/
https://www.ncbi.nlm.nih.gov/pubmed/29971065
http://dx.doi.org/10.3389/fimmu.2018.01387

Ejemplares similares